HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Using reporter gene to compare infection efficiency of HIV-1 pseudovirus to suspended and adherent cells].

AbstractOBJECTIVE:
In order to compare the infection of HIV-1 pseudovirus to suspended and adherent cells, Tzmbl cells containing beta-gal (beta-galactosidase) reporter gene were used here to do the analysis. pseudoviruses were generated by co-transfection of 293T cells with the plasmid pNL43R-E- and HIV envelope expressing plasmid. Supernatant of co-transfected 293T cells was collected and used to infect Tzmbl cells with or without trypsin treatment. Forty-eight hours after infection, beta-gal positive Tzmbl cells and virus infection were determined using X-gal staining and beta-glo (beta-galactosidase) assay.
RESULTS:
The efficiency of HIV pseudoviruses infection of suspended Tzmbl cell was higher than that of adherent cells and the increase of infection correlated with the pseudoviral subtype.
CONCLUSION:
This study may provide a useful method for HIV biological study and neutralization assays using a single-round replicative pseudovirus in the future.
AuthorsYan Su, Lingling Su, Tao Yin, Baojiang Zhang
JournalWei sheng wu xue bao = Acta microbiologica Sinica (Wei Sheng Wu Xue Bao) Vol. 52 Issue 7 Pg. 921-6 (Jul 04 2012) ISSN: 0001-6209 [Print] China
PMID23115978 (Publication Type: Comparative Study, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Suspensions
  • beta-Galactosidase
Topics
  • Cell Adhesion
  • Genes, Reporter (genetics)
  • HEK293 Cells
  • HIV-1 (physiology)
  • Humans
  • Suspensions
  • Transfection
  • Viral Load (genetics)
  • Virus Replication (genetics)
  • beta-Galactosidase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: